243 filings
Page 4 of 13
8-K
7x6ee3os
17 Nov 22
Departure of Directors or Certain Officers
4:10pm
8-K
63rgfv8673l
17 Nov 22
Regulation FD Disclosure
10:24am
8-K
vqkcrw2
14 Nov 22
InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update
5:44pm
S-8
eb460rmjnb2960bwcb
14 Nov 22
Registration of securities for employees
5:16pm
DEFA14A
l1sbyd9u79saihsfdqpd
28 Oct 22
Additional proxy soliciting materials
12:37pm
8-K
p012fhvz0vuwiw j7q8b
26 Oct 22
Regulation FD Disclosure
4:09pm
424B3
b55u4
19 Oct 22
Prospectus supplement
6:10am
EFFECT
snxa1docg18e
19 Oct 22
Notice of effectiveness
12:15am
CORRESP
2kpgjfz
14 Oct 22
Correspondence with SEC
12:00am
UPLOAD
5idvwnsyxqq9hgas
14 Oct 22
Letter from SEC
12:00am
EFFECT
3jz1l8
11 Oct 22
Notice of effectiveness
12:15am
EFFECT
3s051om9xllj57p lyj8
11 Oct 22
Notice of effectiveness
12:15am
EFFECT
ibqt9 3i8c
11 Oct 22
Notice of effectiveness
12:15am
EFFECT
s9tmycha
11 Oct 22
Notice of effectiveness
12:15am
EFFECT
xofl wxd8
11 Oct 22
Notice of effectiveness
12:15am
8-K
mmdee 9pz3tjlz2
29 Sep 22
Other Events
1:52pm
10-K/A
6fw0lfvx0
28 Sep 22
Annual report (amended)
1:34pm